Natco Pharma aims to launch generic of Roche’s rare disease drug after favourable ruling in patent infringement case
The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...
The American Journal of Managed Care3d
Key Considerations for Choosing the Right SMA Treatment
FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...
Rheumatology Advisor6d
Apitegromab Gets Priority Review for Spinal Muscular Atrophy
The FDA has accepted for Priority Review the BLA for apitegromab for the improvement of motor function in patients with spinal muscular atrophy.
SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?
The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug ...
Scottsdale boy beats the odds, paves the way for others at Phoenix Children's and beyond
It's that time of year when you can become a Hero for Hope and donate to ABC15's annual Telethon for Phoenix Children's ...
NIH-funded research saved my life. Don’t take the chainsaw to it.
The NIH is considering a catastrophic cut to indirect cost reimbursements for public universities, which would hurt the ...
Healio6d
Gene therapy improves motor function in spinal muscular atrophy at 52 weeks
Intrathecal treatment with a vector-based gene therapy was associated with a greater improvement in motor function at 52 weeks compared with sham in patients aged 2 to 18 years with spinal muscular ...
'Something special' - Bruno Fernandes issues glowing message after disabled mascot with spinal muscular atrophy joins Man Utd captain in leading out Red Devils for M…
Manchester United captain Bruno Fernandes has issued a message after he was joined by a disabled mascot at Old Trafford ahead ...
Natco Pharma shares legal update on Risdiplam product; stock up 3%
The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...
Newspoint on MSN3d
SC Asks Why SMA Drug Costs More in India Than in Pakistan, China
The Supreme Court has sought a response from the maker of Risdiplam on why the spinal muscular atrophy drug is priced lower ...